Selected research
Market Analysis & Forecast
Global Morphine Market Analysis and Forecast 2026-2032
Market perspective
The global Morphine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Morphine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Morphine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Morphine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Morphine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Morphine include Sun Pharmaceutical Industries, Qinghai Pharmaceutical, Northeast Pharmaceutical Group, Sanofi Winthrop Industrie, Purdue Pharma, Mallinckrodt Pharmaceuticals, Macfarlan Smith and Alcaliber, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Morphine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Morphine, also provides the sales of main regions and countries. Of the upcoming market potential for Morphine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Morphine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Morphine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Morphine sales, projected growth trends, production technology, application and end-user industry.
Morphine Segment by Company
Sun Pharmaceutical Industries
Qinghai Pharmaceutical
Northeast Pharmaceutical Group
Sanofi Winthrop Industrie
Purdue Pharma
Mallinckrodt Pharmaceuticals
Macfarlan Smith
Alcaliber
Morphine Segment by Type
Injection
Oral Tablets
Capsule
Others
Morphine Segment by Application
Diarrhea Suppressant
Cough Suppressant
Anesthesia
Morphine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morphine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Morphine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morphine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Morphine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Morphine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Morphine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Oral Tablets
- Capsule
- Others
Applications
- Diarrhea Suppressant
- Cough Suppressant
- Anesthesia
Companies covered
- Sun Pharmaceutical Industries
- Qinghai Pharmaceutical
- Northeast Pharmaceutical Group
- Sanofi Winthrop Industrie
- Purdue Pharma
- Mallinckrodt Pharmaceuticals
- Macfarlan Smith
- Alcaliber
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Morphine Market by Type
- 1.2.1 Global Morphine Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Injection
- 1.2.3 Oral Tablets
- 1.2.4 Capsule
- 1.2.5 Others
- 1.3 Morphine Market by Application
- 1.3.1 Global Morphine Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Diarrhea Suppressant
- 1.3.3 Cough Suppressant
- 1.3.4 Anesthesia
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Morphine Market Dynamics
- 2.1 Morphine Industry Trends
- 2.2 Morphine Industry Drivers
- 2.3 Morphine Industry Opportunities and Challenges
- 2.4 Morphine Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Morphine Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Morphine Revenue by Region
- 3.2.1 Global Morphine Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Morphine Revenue by Region (2021-2026)
- 3.2.3 Global Morphine Revenue by Region (2027-2032)
- 3.2.4 Global Morphine Revenue Market Share by Region (2021-2032)
- 3.3 Global Morphine Sales Estimates and Forecasts 2021-2032
- 3.4 Global Morphine Sales by Region
- 3.4.1 Global Morphine Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Morphine Sales by Region (2021-2026)
- 3.4.3 Global Morphine Sales by Region (2027-2032)
- 3.4.4 Global Morphine Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Morphine Revenue by Manufacturers
- 4.1.1 Global Morphine Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Morphine Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Morphine Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Morphine Sales by Manufacturers
- 4.2.1 Global Morphine Sales by Manufacturers (2021-2026)
- 4.2.2 Global Morphine Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Morphine Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Morphine Sales Price by Manufacturers (2021-2026)
- 4.4 Global Morphine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Morphine Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Morphine Manufacturers, Product Type & Application
- 4.7 Global Morphine Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Morphine Market CR5 and HHI
- 4.8.2 2025 Morphine Tier 1, Tier 2, and Tier 3
5 Morphine Market by Type
- 5.1 Global Morphine Revenue by Type
- 5.1.1 Global Morphine Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Morphine Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Morphine Revenue Market Share by Type (2021-2032)
- 5.2 Global Morphine Sales by Type
- 5.2.1 Global Morphine Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Morphine Sales by Type (2021-2032) & (tons)
- 5.2.3 Global Morphine Sales Market Share by Type (2021-2032)
- 5.3 Global Morphine Price by Type
6 Morphine Market by Application
- 6.1 Global Morphine Revenue by Application
- 6.1.1 Global Morphine Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Morphine Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Morphine Revenue Market Share by Application (2021-2032)
- 6.2 Global Morphine Sales by Application
- 6.2.1 Global Morphine Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Morphine Sales by Application (2021-2032) & (tons)
- 6.2.3 Global Morphine Sales Market Share by Application (2021-2032)
- 6.3 Global Morphine Price by Application
7 Company Profiles
- 7.1 Sun Pharmaceutical Industries
- 7.1.1 Sun Pharmaceutical Industries Company Information
- 7.1.2 Sun Pharmaceutical Industries Business Overview
- 7.1.3 Sun Pharmaceutical Industries Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Sun Pharmaceutical Industries Morphine Product Portfolio
- 7.1.5 Sun Pharmaceutical Industries Recent Developments
- 7.2 Qinghai Pharmaceutical
- 7.2.1 Qinghai Pharmaceutical Company Information
- 7.2.2 Qinghai Pharmaceutical Business Overview
- 7.2.3 Qinghai Pharmaceutical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Qinghai Pharmaceutical Morphine Product Portfolio
- 7.2.5 Qinghai Pharmaceutical Recent Developments
- 7.3 Northeast Pharmaceutical Group
- 7.3.1 Northeast Pharmaceutical Group Company Information
- 7.3.2 Northeast Pharmaceutical Group Business Overview
- 7.3.3 Northeast Pharmaceutical Group Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Northeast Pharmaceutical Group Morphine Product Portfolio
- 7.3.5 Northeast Pharmaceutical Group Recent Developments
- 7.4 Sanofi Winthrop Industrie
- 7.4.1 Sanofi Winthrop Industrie Company Information
- 7.4.2 Sanofi Winthrop Industrie Business Overview
- 7.4.3 Sanofi Winthrop Industrie Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Sanofi Winthrop Industrie Morphine Product Portfolio
- 7.4.5 Sanofi Winthrop Industrie Recent Developments
- 7.5 Purdue Pharma
- 7.5.1 Purdue Pharma Company Information
- 7.5.2 Purdue Pharma Business Overview
- 7.5.3 Purdue Pharma Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Purdue Pharma Morphine Product Portfolio
- 7.5.5 Purdue Pharma Recent Developments
- 7.6 Mallinckrodt Pharmaceuticals
- 7.6.1 Mallinckrodt Pharmaceuticals Company Information
- 7.6.2 Mallinckrodt Pharmaceuticals Business Overview
- 7.6.3 Mallinckrodt Pharmaceuticals Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Mallinckrodt Pharmaceuticals Morphine Product Portfolio
- 7.6.5 Mallinckrodt Pharmaceuticals Recent Developments
- 7.7 Macfarlan Smith
- 7.7.1 Macfarlan Smith Company Information
- 7.7.2 Macfarlan Smith Business Overview
- 7.7.3 Macfarlan Smith Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Macfarlan Smith Morphine Product Portfolio
- 7.7.5 Macfarlan Smith Recent Developments
- 7.8 Alcaliber
- 7.8.1 Alcaliber Company Information
- 7.8.2 Alcaliber Business Overview
- 7.8.3 Alcaliber Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Alcaliber Morphine Product Portfolio
- 7.8.5 Alcaliber Recent Developments
8 North America
- 8.1 North America Morphine Market Size by Type
- 8.1.1 North America Morphine Revenue by Type (2021-2032)
- 8.1.2 North America Morphine Sales by Type (2021-2032)
- 8.1.3 North America Morphine Price by Type (2021-2032)
- 8.2 North America Morphine Market Size by Application
- 8.2.1 North America Morphine Revenue by Application (2021-2032)
- 8.2.2 North America Morphine Sales by Application (2021-2032)
- 8.2.3 North America Morphine Price by Application (2021-2032)
- 8.3 North America Morphine Market Size by Country
- 8.3.1 North America Morphine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Morphine Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Morphine Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Morphine Market Size by Type
- 9.1.1 Europe Morphine Revenue by Type (2021-2032)
- 9.1.2 Europe Morphine Sales by Type (2021-2032)
- 9.1.3 Europe Morphine Price by Type (2021-2032)
- 9.2 Europe Morphine Market Size by Application
- 9.2.1 Europe Morphine Revenue by Application (2021-2032)
- 9.2.2 Europe Morphine Sales by Application (2021-2032)
- 9.2.3 Europe Morphine Price by Application (2021-2032)
- 9.3 Europe Morphine Market Size by Country
- 9.3.1 Europe Morphine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Morphine Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Morphine Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Morphine Market Size by Type
- 10.1.1 China Morphine Revenue by Type (2021-2032)
- 10.1.2 China Morphine Sales by Type (2021-2032)
- 10.1.3 China Morphine Price by Type (2021-2032)
- 10.2 China Morphine Market Size by Application
- 10.2.1 China Morphine Revenue by Application (2021-2032)
- 10.2.2 China Morphine Sales by Application (2021-2032)
- 10.2.3 China Morphine Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Morphine Market Size by Type
- 11.1.1 Asia Morphine Revenue by Type (2021-2032)
- 11.1.2 Asia Morphine Sales by Type (2021-2032)
- 11.1.3 Asia Morphine Price by Type (2021-2032)
- 11.2 Asia Morphine Market Size by Application
- 11.2.1 Asia Morphine Revenue by Application (2021-2032)
- 11.2.2 Asia Morphine Sales by Application (2021-2032)
- 11.2.3 Asia Morphine Price by Application (2021-2032)
- 11.3 Asia Morphine Market Size by Country
- 11.3.1 Asia Morphine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Morphine Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Morphine Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Morphine Market Size by Type
- 12.1.1 SAMEA Morphine Revenue by Type (2021-2032)
- 12.1.2 SAMEA Morphine Sales by Type (2021-2032)
- 12.1.3 SAMEA Morphine Price by Type (2021-2032)
- 12.2 SAMEA Morphine Market Size by Application
- 12.2.1 SAMEA Morphine Revenue by Application (2021-2032)
- 12.2.2 SAMEA Morphine Sales by Application (2021-2032)
- 12.2.3 SAMEA Morphine Price by Application (2021-2032)
- 12.3 SAMEA Morphine Market Size by Country
- 12.3.1 SAMEA Morphine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Morphine Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Morphine Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Morphine Value Chain Analysis
- 13.1.1 Morphine Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Morphine Production Mode & Process
- 13.2 Morphine Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Morphine Distributors
- 13.2.3 Morphine Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst